Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.56
-1.00 (-7.37%)
At close: Feb 27, 2026, 4:00 PM EST
13.00
+0.44 (3.50%)
After-hours: Feb 27, 2026, 5:36 PM EST

Phathom Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
129.97297.26381.39155.39183.26
Cash & Short-Term Investments
129.97297.26381.39155.39183.26
Cash Growth
-56.28%-22.06%145.45%-15.21%-36.26%
Receivables
78.1338.81.64--
Inventory
5.523.211.21--
Prepaid Expenses
15.3520.8713.195.133.27
Total Current Assets
228.97360.13397.43160.51186.53
Property, Plant & Equipment
3.672.093.623.492.56
Other Long-Term Assets
26.5116.112.790.80.34
Total Assets
259.15378.32413.84164.81189.43
Accounts Payable
4.9810.5112.6105.15
Accrued Expenses
91.6654.9418.3415.5313.28
Current Portion of Long-Term Debt
27.2519.787.11--
Current Portion of Leases
0.650.50.730.710.49
Other Current Liabilities
7.5----
Total Current Liabilities
132.0485.7338.7826.2418.92
Long-Term Debt
559.21534.67437.66204.7989.67
Long-Term Leases
2.07-0.461.11.18
Other Long-Term Liabilities
411.59.77.57.5
Total Liabilities
697.32631.9486.6239.62117.28
Common Stock
0.010.010.0100
Additional Paid-In Capital
1,0461,009855.92652.28601.52
Retained Earnings
-1,484-1,263-928.69-727.09-529.37
Shareholders' Equity
-438.17-253.58-72.76-74.8172.16
Total Liabilities & Equity
259.15378.32413.84164.81189.43
Total Debt
589.17554.95445.96206.691.34
Net Cash (Debt)
-459.2-257.69-64.56-51.2191.92
Net Cash Growth
-----61.46%
Net Cash Per Share
-6.30-4.08-1.26-1.312.48
Filing Date Shares Outstanding
78.869.6458.4841.7230.57
Total Common Shares Outstanding
71.4268.5257.9741.4730.51
Working Capital
96.93274.41358.65134.28167.61
Book Value Per Share
-6.14-3.70-1.26-1.802.36
Tangible Book Value
-438.17-253.58-72.76-74.8172.16
Tangible Book Value Per Share
-6.14-3.70-1.26-1.802.36
Machinery
4.34.164.052.161.43
Construction In Progress
---0.4-
Leasehold Improvements
0.240.160.140.120.08
Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q